Literature DB >> 15473146

Population-based Toxoplasma seroprevalence study in The Netherlands.

L M Kortbeek1, H E De Melker, I K Veldhuijzen, M A E Conyn-Van Spaendonck.   

Abstract

During 1995--1996 a population-based seroprevalence study was conducted in The Netherlands. Risk factors were established for postnatally acquired toxoplasmosis. The results were compared with a study conducted during 1987-1988 in pregnant women in the Southwest of The Netherlands in order to estimate the change in seroprevalence. In total, 7521 sera were tested and the national seroprevalence was 40.5 % (95 % CI 37.5-43.4). Living in the Northwest, having professional contact with animals, living in a moderately urbanized area, being divorced or widowed, being born outside The Netherlands, frequent gardening and owning a cat were independently associated with Toxoplasma seropositivity. Risk factors like eating undercooked meat could not be studied. The seroprevalence among women aged 15-49 years was 10 % lower (35.2 %, 95 % CI 32.9-38.6) in the study of 1995-1996, compared to the Toxoplasma study of 1987--1988 (45.8 %, 95 % CI 45.2-46.3). The steepest rise in seroprevalence still occurred among the subjects aged 25-44 years.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15473146      PMCID: PMC2870170          DOI: 10.1017/s0950268804002535

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Detection of toxoplasmosis in patients with end-stage renal disease by enzyme-linked immunosorbent assay and polymerase chain reaction methods.

Authors:  J Saki; S Khademvatan; S Soltani; H Shahbazian
Journal:  Parasitol Res       Date:  2012-09-20       Impact factor: 2.289

2.  The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.

Authors:  D R Schmidt; B Hogh; O Andersen; J Fuchs; H Fledelius; E Petersen
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

3.  Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso.

Authors:  Sanata Bamba; Mamoudou Cissé; Ibrahim Sangaré; Adama Zida; Souleymane Ouattara; Robert T Guiguemdé
Journal:  BMC Infect Dis       Date:  2017-07-11       Impact factor: 3.090

4.  A critical assessment of the association between postnatal toxoplasmosis and epilepsy in immune-competent patients.

Authors:  J W Uzorka; S M Arend
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-12       Impact factor: 3.267

5.  Cross-Sectional Survey on Toxoplasma gondii Infection in Cattle, Sheep, and Goats in Algeria: Seroprevalence and Risk Factors.

Authors:  Mohamed-Cherif Abdallah; Miroud Kamel; Benfodil Karima; Ansel Samir; Khelef Djamel; Kaidi Rachid; Ait-Oudhia Khatima
Journal:  Vet Sci       Date:  2019-07-10

6.  Abstracts of the 21st ECCMID (European Society of Clinical Microbiology and Infectious Diseases)/27th ICC. Milan, Italy. May 7-10, 2011.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2011-05       Impact factor: 8.067

7.  The association between antibodies to neurotropic pathogens and bipolar disorder : A study in the Dutch Bipolar (DB) Cohort and meta-analysis.

Authors:  Gijsje J L J Snijders; Hans C van Mierlo; Marco P Boks; Marieke J H Begemann; Arjen L Sutterland; Manja Litjens; Roel A Ophoff; René S Kahn; Lot D de Witte
Journal:  Transl Psychiatry       Date:  2019-11-20       Impact factor: 6.222

8.  Toxoplasma seroprevalence in a rural population in France: detection of a household effect.

Authors:  Emmanuelle Gilot Fromont; Benjamin Riche; Muriel Rabilloud
Journal:  BMC Infect Dis       Date:  2009-05-28       Impact factor: 3.090

9.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study.

Authors:  Hendrik Wilking; Michael Thamm; Klaus Stark; Toni Aebischer; Frank Seeber
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.